Clean Intermittant Self Catheterisation: A Trial Comparing Single Use vs Reuse of Nelaton Catheters

Clean Intermittant Self Catheterisation: A Randomised Control Trial Comparing Single Use vs Reuse of Nelaton Catheters

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01404481

Acronym

SURE

Enrollment

Registered

2011-07-28

Start date

2010-03-31

Completion date

2013-04-30

Last updated

2015-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Retention

Keywords

Urinary retention, CISC, Single use, Re use

Brief summary

The purpose of the study is to compare single use of catheters with reuse of catheters for intermittant self catheterisation.

Detailed description

Patients with voiding dysfunction and chronic urinary retention are taught the technique Clean Intermittent Self Catheterisation (CISC) by specialist Nurse Continence Advisors. For several decades, patients have been taught to catheterise using a clean technique where they rinse their catheter under tap water and store the catheter in a sterile solution (e.g. Milton). The catheter is re-used for up to one week. The risk of urinary tract infection (UTI) was known to be minimal (and certainly much less than having a permanent indwelling catheter). Recently, the Therapeutics Goods Administration has issued a guideline that CISC catheters should be single-use items but no data to support this guideline appears to have been collected. The aim of this project is to assess the incidence of urinary tract infection (UTI) when comparing single-use catheters with re-use of catheters for CISC, and to determine the cost differences between the two methods.

Interventions

DEVICEclean intermittent self catheterisation single use vs re use

Over the 16 week period all patient will participate in 8 weeks of single use cathetersation and 8 weeks of re use catheterisation. The study is a randomised control crossover trial

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* over 18 years old * CISC \> 2/day * No current symptomatic UTI * Willing to change catheter use method

Exclusion criteria

* Symptomatic Urinary Tract infection despite treatment * \<18 years old

Design outcomes

Primary

Measure	Time frame	Description
Rate of Urinary Tract Infection	16 weeks	Urine specimens are sent at 4 weekly intervals over 16 weeks to check for Urinary tract infection

Secondary

Measure	Time frame	Description
Economic Cost	16 weeks	Difference in econimic cost of single use Catheterisation and re use catheterisation and the impact on the patient

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026